185 related articles for article (PubMed ID: 21184668)
1. Therapeutic approach to multiple sclerosis by novel oral drug.
Jadidi-Niaragh F; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):66-80. PubMed ID: 21184668
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: a brief overview.
Mulakayala N; Rao P; Iqbal J; Bandichhor R; Oruganti S
Eur J Med Chem; 2013 Feb; 60():170-86. PubMed ID: 23291119
[TBL] [Abstract][Full Text] [Related]
3. [Emerging therapies for multiple sclerosis].
de Lorenzo-Pinto A; Rodríguez-González CG; Ais-Larisgoitia A
Med Clin (Barc); 2013 Jan; 140(2):76-82. PubMed ID: 22766059
[TBL] [Abstract][Full Text] [Related]
4. Emerging oral drugs for multiple sclerosis.
Gasperini C; Cefaro LA; Borriello G; Tosto G; Prosperini L; Pozzilli C
Expert Opin Emerg Drugs; 2008 Sep; 13(3):465-77. PubMed ID: 18764723
[TBL] [Abstract][Full Text] [Related]
5. Drugs: An injection of hope.
Graham-Rowe D
Nature; 2012 Apr; 484(7393):S4. PubMed ID: 22509505
[No Abstract] [Full Text] [Related]
6. New oral drugs for multiple sclerosis.
Gasperini C; Ruggieri S
Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment for multiple sclerosis.
Killestein J; Rudick RA; Polman CH
Lancet Neurol; 2011 Nov; 10(11):1026-34. PubMed ID: 22014437
[TBL] [Abstract][Full Text] [Related]
8. The future of multiple sclerosis therapy.
Kieseier BC; Wiendl H; Hartung HP; Stüve O
Pharmacol Res; 2009 Oct; 60(4):207-11. PubMed ID: 19717009
[TBL] [Abstract][Full Text] [Related]
9. Neurotherapeutics in multiple sclerosis: novel agents and emerging treatment strategies.
DeAngelis T; Lublin F
Mt Sinai J Med; 2008; 75(2):157-67. PubMed ID: 18500719
[TBL] [Abstract][Full Text] [Related]
10. Novel oral agents for multiple sclerosis.
Burton JM; O'Connor P
Curr Neurol Neurosci Rep; 2007 May; 7(3):223-30. PubMed ID: 17488588
[TBL] [Abstract][Full Text] [Related]
11. [Current treatment of multiple sclerosis].
Csépány T
Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis therapies: molecular mechanisms and future.
Fontoura P; Garren H
Results Probl Cell Differ; 2010; 51():259-85. PubMed ID: 20838962
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.
Hohlfeld R
Nat Rev Neurol; 2011 Jul; 7(8):425-7. PubMed ID: 21750524
[No Abstract] [Full Text] [Related]
14. New drugs may improve, complicate treatment for multiple sclerosis.
Link H; Martin R
Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
[No Abstract] [Full Text] [Related]
15. Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
Thomas RH; Wakefield RA
Am J Health Syst Pharm; 2015 Jan; 72(1):25-38. PubMed ID: 25511835
[TBL] [Abstract][Full Text] [Related]
16. Oral Therapies for Multiple Sclerosis.
Faissner S; Gold R
Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29500302
[TBL] [Abstract][Full Text] [Related]
17. A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.
Lu E; Wang BW; Alwan S; Synnes A; Dahlgren L; Sadovnick AD; Tremlett H
CNS Drugs; 2014 Feb; 28(2):89-94. PubMed ID: 24343726
[TBL] [Abstract][Full Text] [Related]
18. [Development of oral therapies for multiple sclerosis--fingolimod, cladribine and other drugs].
Hecht B
Med Monatsschr Pharm; 2010 Apr; 33(4):120-30; quiz 131-2. PubMed ID: 20429402
[TBL] [Abstract][Full Text] [Related]
19. Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Gold R
CNS Drugs; 2011 Jan; 25(1):37-52. PubMed ID: 21128693
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
Hutchinson M; Fox RJ; Havrdova E; Kurukulasuriya NC; Sarda SP; Agarwal S; Siddiqui MK; Taneja A; Deniz B
Curr Med Res Opin; 2014 Apr; 30(4):613-27. PubMed ID: 24195574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
